Related Experiment Videos
CD20-positive infiltrates in human membranous glomerulonephritis
Clemens D Cohen1, Novella Calvaresi, Silvia Armelloni
1Medizinische Poliklinik, Nephrologisches Zentrum, Ludwig-Maximilians-University, Munich, Germany.
Journal of Nephrology
|July 14, 2005
Summary
B cells play a role in membranous glomerulonephritis (MGN), a common cause of nephrotic syndrome. Increased CD20 mRNA and B cell infiltration in MGN patients suggest their involvement in disease pathogenesis.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Membranous glomerulonephritis (MGN) is the leading cause of nephrotic syndrome in adults.
- Current hypotheses suggest antibodies against podocyte antigens drive MGN pathogenesis.
- The precise role of B cells in MGN remains unclear, despite B cell depletion therapy efficacy.
Purpose of the Study:
- To investigate the interstitial expression of CD20 mRNA and B cell infiltration in MGN patients.
- To determine if B cells are involved in the pathogenesis of MGN.
- To explore the potential of intrarenal CD20 quantification for predicting treatment response.
Main Methods:
- Quantified CD20 mRNA expression in kidney biopsies from 31 MGN patients and controls.
- Utilized immunohistochemistry to detect interstitial B cell infiltration in MGN and minimal change disease (MCD) patients.
- Compared CD20 mRNA levels and B cell infiltration between MGN patients and various control groups.
Main Results:
- CD20 mRNA expression was significantly elevated in MGN patients compared to controls.
- Focal or diffuse interstitial B cell infiltration was observed in MGN patients but was minimal or absent in MCD patients.
- These findings indicate a higher presence of B cells in the kidneys of MGN patients.
Conclusions:
- B cells are likely involved in the pathogenesis of membranous glomerulonephritis.
- B cells may function as antigen-presenting cells in MGN.
- Intrarenal CD20 quantification could potentially guide B cell depletion therapy selection for MGN.